Case 3. Depigmentation in a chronic myeloid leukemia patient treated with STI-571

Journal of Clinical Oncology

Volumn 20, Issue 3, 2002, Pages 869-870

  Raanani, Pia ^a   Goldman, John M ^a   Ben Bassat, Isaac ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTARABINE; HYDROXYUREA; IMATINIB; PROTEIN TYROSINE KINASE; STEM CELL FACTOR RECEPTOR; ANTINEOPLASTIC AGENT; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL EXAMINATION; DEPIGMENTATION; HUMAN; MALE; MELANOCYTE; MELANOGENESIS; PATHOPHYSIOLOGY; PIEBALDISM; PRIORITY JOURNAL; VITILIGO; CHEMICALLY INDUCED DISORDER; HYPOPIGMENTATION; MIDDLE AGED;

ANTINEOPLASTIC AGENTS; HUMANS; HYPOPIGMENTATION; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; PIPERAZINES; PYRIMIDINES;

EID: 0036468137     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.2002.20.3.869     Document Type: Article

References (8)

1. Dermatologic toxicity
2. Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor
3. Abl protein-tyrosine kinase inhibitor ST1571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors
4. White mutants in mice shedding light on humans
5. Coordinated mRNA expression of c-kit with tyrosinase and TRP-1 in melanin pigmentation of normal and malignant human melanocytes and transient activation of tyrosinase by Kit/SCF-R
6. Signaling and transcriptional regulation in the neural crest-derived melanocyte lineage: Interactions between KIT and MITF
7. Expression of the c-kit receptor in hypomelanosis: A comparative study between piebaldism, naevus depigmentosus and vitiligo
8. A novel KIT mutation results in piebaldism with progressive depigmentation